The EPS projection of Pharmerica Corporation (NYSE:PMC) for quarter ended 2016-09-30 is $0.52. Last week, the EPS forecast was $0.52 against target of $0.52, a month earlier. Two months ago, this estimate was $0.52 versus forecast of $0.52 three months earlier, implying a deviation of 0%.
Pharmerica Corporation (NYSE:PMC) stated that 18 days ago, its stock price was positively revised 0 times while negative revisions were 1.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 1, 2, and 2, correspondingly.
EPS estimate downgrade for Pharmerica Corporation (NYSE:PMC) in the preceding 30, 120, 60 and 90 days were 0, 1, 0, and 0, correspondingly.
Pharmerica Corporation (NYSE:PMC) EPS target for the quarter closed 1 was $0.52, based on 2 recommendations. As reported on 2016-05-06 the EPS was $0.45. The change was $0.08, implying a percentage deviation of 21.62%. The projections showed a standard deviation of 0.01.
Quarterly Sales Estimates
Pharmerica Corporation (NYSE:PMC) yearly sales prediction for the fiscal 2016 stands at $542.75 and the median estimate is at $542.75. Almost 2 analysts issued sales target.
Highest sales target is $550 while the lowest target is $535.5 showing standard deviation of 10.253%.
As many as 2 analysts have sales targets revised upside while 2 reduced sales estimates, implying a deviation of 0%.
Last month, 2 revised sales number projection on upside while 2 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 2 hiked sales target and 2 reduced sales forecast. Pharmerica Corporation (NYSE:PMC) announced that the deviation in forecast was -1.354%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...